Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06414148
Title MRD-Directed Consolidation With Epcor-only or Epcor-R2 Post Anti-CD19 CAR TCell Therapy for Large B-Cell Lymphoma (EpLCART)
Acronym EpLCART
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Peter MacCallum Cancer Centre, Australia
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Royal Prince Alfred Hospital NOT_YET_RECRUITING Camperdown New South Wales 2050 Australia Details
Westmead Hospital RECRUITING Westmead New South Wales 2145 Australia Details
Royal Brisbane and Women's Hospital NOT_YET_RECRUITING Herston Queensland 4029 Australia Details
Alfred Hospital RECRUITING Melbourne Victoria 3000 Australia Details
Peter MacCallum Cancer Centre RECRUITING Melbourne Victoria 3000 Australia Details
Fiona Stanley Hospital NOT_YET_RECRUITING Murdoch Western Australia 6150 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field